Skip to content

LISATA THERAPEUTICS, INC.

LSTA

CIK 0000320017

← back to feed
Revenue (TTM)
$70K
−83.0% YoY Q1 May 2026
Net Income (TTM)
−$18.12M
+17.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.08
+20.4% YoY Q1 May 2026
Gross Margin
2,390.9%
Q1 May 2026
Operating Margin
-28,672.9%
Q1 May 2026
Net Margin
-25,887.1%
Q1 May 2026
Free Cash Flow (TTM)
−$23.74M
Q1 May 2026
Cash
$13.06M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
9.11M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings